GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Oracle Healthcare Acquisition Corp (OTCPK:OHAQ) » Definitions » EBITDA

Oracle Healthcare Acquisition (Oracle Healthcare Acquisition) EBITDA : $5.23 Mil (TTM As of Dec. 2007)


View and export this data going back to 2006. Start your Free Trial

What is Oracle Healthcare Acquisition EBITDA?

Oracle Healthcare Acquisition's EBITDA for the three months ended in Dec. 2007 was $5.62 Mil. Its EBITDA for the trailing twelve months (TTM) ended in Dec. 2007 was $5.23 Mil.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

Oracle Healthcare Acquisition's EBITDA per Share for the three months ended in Dec. 2007 was $0.25. Its EBITDA per share for the trailing twelve months (TTM) ended in Dec. 2007 was $0.23.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.


Oracle Healthcare Acquisition EBITDA Historical Data

The historical data trend for Oracle Healthcare Acquisition's EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oracle Healthcare Acquisition EBITDA Chart

Oracle Healthcare Acquisition Annual Data
Trend Dec05 Dec06 Dec07
EBITDA
- 4.28 5.23

Oracle Healthcare Acquisition Quarterly Data
Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07
EBITDA Get a 7-Day Free Trial 4.76 -0.34 0.10 -0.15 5.62

Competitive Comparison of Oracle Healthcare Acquisition's EBITDA

For the Medical Care Facilities subindustry, Oracle Healthcare Acquisition's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oracle Healthcare Acquisition's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Oracle Healthcare Acquisition's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Oracle Healthcare Acquisition's EV-to-EBITDA falls into.


Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Oracle Healthcare Acquisition's EBITDA for the fiscal year that ended in Dec. 2007 is calculated as

Oracle Healthcare Acquisition's EBITDA was directly provided by GuruFocus' data source Morningstar. For the fiscal year ended in Dec. 2007, Oracle Healthcare Acquisition's EBITDA was $5.23 Mil.

Oracle Healthcare Acquisition's EBITDA for the quarter that ended in Dec. 2007 is calculated as

Oracle Healthcare Acquisition's EBITDA was directly provided by GuruFocus' data source Morningstar. For the quarter ended in Dec. 2007, Oracle Healthcare Acquisition's EBITDA was $5.62 Mil.

EBITDA for the trailing twelve months (TTM) ended in Dec. 2007 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.23 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

Oracle Healthcare Acquisition  (OTCPK:OHAQ) EBITDA Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also Price-to-EBITDA is sometimes used in valuations.


Oracle Healthcare Acquisition EBITDA Related Terms

Thank you for viewing the detailed overview of Oracle Healthcare Acquisition's EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Oracle Healthcare Acquisition (Oracle Healthcare Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
Website
Executives
Andrew M Weiss 10 percent owner 222 BERKELEY STREET, 16TH FLOOR, BOSTON MA 02116
Jeffrey Tannenbaum 10 percent owner 505 FIFTH AVENUE, 23RD FLOOR, NEW YORK NY 10017
Fir Tree Inc. 10 percent owner 500 FIFTH AVENUE, 9TH FLOOR, NEW YORK NY 10110
Camellia Partners, Llc 10 percent owner 51 BEDFORD ROAD, SUITES 3 & 4, KATONAH NY 10536
Andrew Fredman 10 percent owner 7301 SW 57TH COURT, SUITE 410, SOUTH MIAMI FL 33143
Fir Tree, L.l.c. 10 percent owner 505 FIFTH AVENUE, 23RD FLOOR, NEW YORK NY 10017
Per Gh Lofberg director C/O MERCK CAPITAL VENTURES, 50 TICE BLVD, WOODCLIFF NJ 07677
Larry N Feinberg director, 10 percent owner C/O ORACLE PARTNERS L P, 200 GREENWICH AVENUE, GREENWICH CT 06830
George Bickerstaff director C/O VION PHARMACEUTICALS, INC., 4 SCIENCE PARK, NEW HAVEN CT 06511
Kevin C Johnson director 12 KEELERS RIDGE ROAD, WILTON CT 06897
Mark A Radzik officer: CFO & Secretary
Joel D Liffman director, officer: President and COO C/O ORACLE STRATEGIES PARTNERS, L.P., 712 FIFTH AVENUE, 45TH FLOOR, NEW YORK NY 10019

Oracle Healthcare Acquisition (Oracle Healthcare Acquisition) Headlines

No Headlines